Calendar Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
3.85 USD -7.89% Intraday chart for Eliem Therapeutics, Inc. -18.95% +42.59%

Chart calendar Eliem Therapeutics, Inc.

b50d3.BAgSj3Lh7xwEmhKj501ur8AmOmVAqAi9wZJzQ8HNoQs.KWRUuDq4n2xX7kjl0gs_yKRyCS4Mw2rzgOZKMoWJ5mNgOGLVG6OKd0D_Vw~c4a7fd11072e208316aa2a71feb1b5d0

Upcoming events on Eliem Therapeutics, Inc.

2024-05-12 Q1 2024 Earnings Release (Projected)

Past events on Eliem Therapeutics, Inc.

2024-04-11 08:30 am Acquisition of Tenet Medicines Inc by Eliem Therapeutics Inc Call
2023-09-12 International Kv7 Channels Symposium
2023-05-30 Epilepsy Therapies & Diagnostics Development Conference
2023-05-17 Annual General Meeting
2023-05-11 04:10 pm Q1 2023 Earnings Release
2023-03-26 RSC BMCS SCI Symposium
2023-03-06 04:10 pm Q4 2022 Earnings Release
2022-12-01 11:40 am Evercore ISI HealthCONx Conference
2022-11-16 01:50 pm Stifel Healthcare Conference
2022-11-15 10:10 am Guggenheim Immunology and Neurology Conference
2022-11-14 06:10 am Q3 2022 Earnings Release
2022-08-15 06:10 am Interim 2022 Earnings Release
2022-07-21 10:30 am Investor Meeting
2022-05-19 01:00 pm Annual General Meeting
2022-05-16 06:10 am Q1 2022 Earnings Release
2022-03-29 09:30 am Stifel CNS Day
2022-03-07 04:10 pm FY 2021 Earnings Release
2022-02-18 03:00 pm SVB Leerink Global Healthcare Conference
2022-02-16 10:30 am Investor Meeting
2021-12-01 03:05 pm Evercore ISI HealthCONx Conference

Annual results

Fiscal PeriodDecember 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
0,00


-35,7
-38,0
6%
-45,1
-46,3
2.43%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-47,5
-49,9
4.85%
-45,2
-48,2
6.05%
Net income
Million USD
Released
Forecast
Spread
-20,7


-52,0
-57,5
9.46%
-45,2
-47,4
4.63%
EPS
USD
Released
Forecast
Spread
-5,25


-4,24
-6,32
32.91%
-1,72
-1,73
0.39%
Announcement Date21/06/2107/03/2206/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-10,7
-13,0
17.35%
-13,1
-15,2
13.32%
-13,7
-13,1
-4.59%
-8,75
-13,5
34.96%
-9,55
-8,80
-8.57%
-23,4
-7,79
-200.78%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-10,5
-13,0
18.57%
-13,2
-15,2
12.84%
-14,6
-13,1
-11.42%
-9,68
-13,5
28.01%
-7,76
-8,80
11.8%
-22,3
-7,79
-186.04%
Net income
Million USD
Released
Forecast
Spread
-10,5
-16,0
33.96%
-13,2
-14,8
10.78%
-14,6
-12,4
-18.03%
-9,68
-12,6
23.16%
-7,76
-8,65
10.27%
-22,3
-6,63
-236.28%
EPS
USD
Released
Forecast
Spread
1,25
-0,63
298.41%
-0,50
-0,56
11.24%
-0,56
-0,47
-20%
-0,37
-0,43
14.45%
-0,29
-0,33
13%
-0,84
-0,25
-236%
Announcement Date07/03/2216/05/2215/08/2214/11/2206/03/2311/05/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ELYM Stock
  4. Calendar Eliem Therapeutics, Inc.